Diagnostics & Tools April 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Diagnostics & Tools industry totaled eleven mergers & acquisitions and twenty-five financings during the month of April
• In terms of M&A, In Vitro Diagnostics was the most active this month, with 4 transactions; while in terms of financing, Life Science Tools was the most active, with 9 financings
• Total disclosed M&A value was $416.8 million, while financings totaled $277.2 million during the month of April
• The largest disclosed M&A transaction this month was the $239.5 million acquisition of Cisbio Assays by PerkinElmer, Inc., while the largest financing was $50 million raised by Everly Well, Inc.
• M&A and financings in the United States accounted for 45% and 40% of total transactions this month, down 32% and 36%, respectively
• M&A activity this month includes acquisitions by PerkinElmer, Todos Medical, Canopy Biosciences, and Yourgene Health